Last updated March 8th 2017

March 1, 2016 | Israeli personalized medication management platform Medisafe announced today that it has raised a $14.5 million in a Series B funding round led by Octopus Ventures, with M (Merck)Ventures, to support the company’s rapid growth and global expansion. Other investors participating from previous rounds include Pitango Venture Capital, 7wire ventures, lool Ventures, TriVentures and Qualcomm Ventures. With over 3.5 million patient and caregiver registered users, Medisafe focuses on helping the hundreds of millions of people worldwide to take their medications as prescribed, solving the problem known as medication non-adherence. Based in Haifa, Medisafe was founded by CEO Omri Shor and CTO Rotem Shor.